tiprankstipranks
Analyst Profile
Followed by 25 other investors
.
Matthew Mishan

Matthew Mishan

KeyBanc
Wall Street Analyst
Ranked #1,610 out of 8,045 Analysts on TipRanks (#2,894 out of 21,519 overall experts)

Success Rate

58%
83 out of 143 Profitable Transactions

Average Return

7.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Matthew Mishan's ratings since 2015 and opened each position for the duration of 1 Year:
58.04% of your transactions would have been profitable with an average return of 7.3%

Stock Rating Distribution

189Ratings
80.42% Buy
19.58% Hold
0.00% Sell
Distribution of Matthew Mishan's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Hill-Rom Holdings
(HRC)
Rating Type:Buy
Dates:Oct 01, 2020 - Sep 07, 2021
Gain:86.20%
The most profitable rating made by Matthew Mishan

Matthew Mishan's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
PerkinElmer
May 04, 2015
Hold
Downgraded
0.00%
1
IDEX
May 23, 2016
Hold
Assigned
0.00%
1
Thermo Fisher
Jun 08, 2016
Buy
Reiterated
$167.00
(-72.37% Downside)
100%
+13.80%
1
PTHN
Patheon NV
Aug 15, 2016
Buy
Initiated
100%
+26.90%
1
BCR
CR Bard
May 30, 2017
Hold
Reiterated
0.00%
2
UniFirst
Sep 26, 2017
Hold
Reiterated
0.00%
1
Conmed
Nov 03, 2017
Hold
Reiterated
0.00%
2
Catalent
Mar 28, 2018
Buy
Upgraded
75%
+50.50%
5
Invacare
Aug 15, 2018
Hold
Downgraded
33%
+4.32%
8
CMD
Cantel Medical
Dec 07, 2018
Hold
Initiated
0.00%
1
List of latest recommendations made by Matthew Mishan. Click to expand and see Matthew Mishan's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More